Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
976
Puma Biotechnology
PBYI
$531M
| $15.3M | 0.01% |
1,465,697
+377,100
| +35% | +$3.9M |
2019 Q4
2 quarters
|
|
977
DELISTED
ChemoCentryx, Inc.
CCXI
| $15.3M | 0.01% |
265,100
-58,200
| -18% | -$3.17M |
2013 Q4
26 quarters
|
|
978
Independent Bank Corp
IBCP
$785M
| $15.2M | 0.01% |
1,024,200
-10,600
| -1% | -$146K |
2013 Q2
28 quarters
|
|
979
Saul Centers
BFS
$742M
| $15.2M | 0.01% |
470,174
-111,000
| -19% | -$3.54M |
2013 Q2
28 quarters
|
|
980
Ligand Pharmaceuticals
LGND
$6.02B
| $15.2M | 0.01% |
217,277
-744,433
| -77% | -$47.2M |
2017 Q4
10 quarters
|
|
981
Great Southern Bancorp
GSBC
$836M
| $15.1M | 0.01% |
374,600
-13,700
| -4% | -$542K |
2013 Q2
28 quarters
|
|
|
GCAP
982
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $15.1M | 0.01% |
2,511,104
+1,413,300
| +129% | +$8.7M |
2018 Q3
7 quarters
|
|
983
DELISTED
Vista Outdoor Inc.
VSTO
| $15.1M | 0.01% |
1,046,000
-166,500
| -14% | -$1.67M |
2017 Q4
10 quarters
|
|
984
Paysign
PAYS
$868M
| $15.1M | 0.01% |
1,555,150
-330,300
| -18% | -$2.44M |
2019 Q2
4 quarters
|
|
985
News Corp Class B
NWS
$17.2B
| $15.1M | 0.01% |
1,262,653
-209,300
| -14% | -$2.27M |
2016 Q2
16 quarters
|
|
986
Williams Companies
WMB
$88.9B
| $15.1M | 0.01% |
+793,285
| New | +$14.8M |
2020 Q2
0 quarters
|
|
987
Liquidity Services
LQDT
$1.35B
| $15M | 0.01% |
2,523,972
+156,508
| +7% | +$830K |
2014 Q3
23 quarters
|
|
988
PPL Corp
PPL
$25.8B
| $15M | 0.01% |
580,900
-3,144,131
| -84% | -$81.8M |
2017 Q2
12 quarters
|
|
|
CEL
989
DELISTED
Cellcom Israel, Ltd.
CEL
| $15M | 0.01% |
3,831,642
+15,900
| +0.4% | +$55.4K |
2013 Q2
28 quarters
|
|
990
Brown-Forman Class A
BF.A
$12.3B
| $14.9M | 0.01% |
258,600
-8,629
| -3% | -$503K |
2013 Q2
28 quarters
|
|
|
Y
991
DELISTED
Alleghany Corp
Y
| $14.8M | 0.01% |
30,188
+7,300
| +32% | +$3.78M |
2013 Q3
27 quarters
|
|
992
First Industrial Realty Trust
FR
$7.88B
| $14.7M | 0.01% |
382,900
-294,601
| -43% | -$10.8M |
2016 Q4
14 quarters
|
|
993
Strategy Inc
MSTR
$61.5B
| $14.7M | 0.01% |
1,244,000
+940,000
| +309% | +$11.4M |
2013 Q2
28 quarters
|
|
994
DELISTED
Avangrid, Inc.
AGR
| $14.6M | 0.01% |
347,741
-836,800
| -71% | -$35.9M |
2016 Q2
16 quarters
|
|
995
Lakeland Industries
LAKE
$98.9M
| $14.6M | 0.01% |
649,802
+9,400
| +1% | +$154K |
2014 Q4
22 quarters
|
|
996
Unilever
UL
$134B
| $14.6M | 0.01% |
235,822
-536,408
| -69% | -$32.1M |
2017 Q4
10 quarters
|
|
997
Equifax
EFX
$17.1B
| $14.6M | 0.01% |
+84,695
| New | +$12.5M |
2020 Q2
0 quarters
|
|
|
IVC
998
DELISTED
Invacare Corporation
IVC
| $14.5M | 0.01% |
2,283,969
-63,700
| -3% | -$426K |
2018 Q4
6 quarters
|
|
999
Curtiss-Wright
CW
$18.9B
| $14.5M | 0.01% |
162,900
+3,125
| +2% | +$298K |
2018 Q1
9 quarters
|
|
1000
Cimpress
CMPR
$1.81B
| $14.5M | 0.01% |
190,300
-39,100
| -17% | -$2.78M |
2019 Q4
2 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.